Liang Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Liang Wang has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Ann Ly
Department of Urology, University of California, Los Angeles, California. 1
64 shared publications - Arnold I. Chin
University of California, Los Angeles 4 Los Angeles, CA
64 shared publications - Emily Chou
Department of Medicine, University of California Irvine Medical Center, Orange, California, USA
64 shared publications - Hanwei Zhang
Department of Urology, University of California, Los Angeles, California. 1
64 shared publications - Kris Prado
Department of Urology, Stanford University, Stanford, USA
64 shared publications - Matteo Pellegrini
Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, USA
64 shared publications
Latest Publications
- Open Access
- 25 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-15
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Chronic prostate inflammation in patients with benign prostate hyperplasia (BPH) correlates with the severity of symptoms. How inflammation contributes to prostate enlargement and/or BPH symptoms and the underlying mechanisms remain unclear. In this study, we utilize a unique transgenic mouse model that mimics chronic non-bacterial prostatitis in men and investigate the impact of inflammation on androgen receptor (AR) in basal prostate stem cells (bPSC) and their differentiation in vivo. We find that inflammation significantly enhances AR levels and activity in bPSC. More importantly, we identify interleukin 1 receptor antagonist (IL-1RA) as a crucial regulator of AR in bPSC during inflammation. IL-1RA is one of the top molecules upregulated by inflammation, and inhibiting IL-1RA reverses the enhanced AR activity in organoids derived from inflamed bPSC. Additionally, IL-1RA appears to activate AR by counteracting IL-1α's inhibitory effect. Furthermore, using a lineage tracing model, we observe that inflammation induces bPSC proliferation and differentiation into luminal cells even under castrate conditions, indicating that AR activation driven by inflammation is sufficient to promote bPSC proliferation and differentiation. Taken together, our study uncovers mechanisms through which inflammation modulates AR signaling in bPSC and induces bPSC luminal differentiation that may contribute to prostate hyperplasia.
- 25 October 2024
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-15
Open AccessInflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
Chronic prostate inflammation in patients with benign prostate hyperplasia (BPH) correlates with the severity of symptoms. How inflammation contributes to prostate enlargement and/or BPH symptoms and the underlying mechanisms remain unclear. In this study, we utilize a unique transgenic mouse model that mimics chronic non-bacterial prostatitis in men and investigate the impact of inflammation on androgen receptor (AR) in basal prostate stem cells (bPSC) and their differentiation in vivo. We find that inflammation significantly enhances AR levels and activity in bPSC. More importantly, we identify interleukin 1 receptor antagonist (IL-1RA) as a crucial regulator of AR in bPSC during inflammation. IL-1RA is one of the top molecules upregulated by inflammation, and inhibiting IL-1RA reverses the enhanced AR activity in organoids derived from inflamed bPSC. Additionally, IL-1RA appears to activate AR by counteracting IL-1α's inhibitory effect. Furthermore, using a lineage tracing model, we observe that inflammation induces bPSC proliferation and differentiation into luminal cells even under castrate conditions, indicating that AR activation driven by inflammation is sufficient to promote bPSC proliferation and differentiation. Taken together, our study uncovers mechanisms through which inflammation modulates AR signaling in bPSC and induces bPSC luminal differentiation that may contribute to prostate hyperplasia.
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
FDRs and p-values of IFNgamma induced genes
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
FDRs and p-values of IFNgamma induced genes
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 5 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Normalized gene expression of RNA sequencing
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 5 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Normalized gene expression of RNA sequencing
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Exposure times of antibodies used for immunofluorescence
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Exposure times of antibodies used for immunofluorescence
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Exposure times of antibodies used for immunofluorescence
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Exposure times of antibodies used for immunofluorescence
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
FOXP3 antibodies not sufficient for ChIP Sequencing
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
FOXP3 antibodies not sufficient for ChIP Sequencing
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 3 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Minimal activation of PD-L1 by IL-4 and IL-10 compared to IFNgamma in HT1376 cells
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 3 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Minimal activation of PD-L1 by IL-4 and IL-10 compared to IFNgamma in HT1376 cells
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Generation of MB49 FOXP3 knockout cells by flow cytometry and Western blot. Immunofluorescence of chromogranin A and NSE.
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 6 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Generation of MB49 FOXP3 knockout cells by flow cytometry and Western blot. Immunofluorescence of chromogranin A and NSE.
- Open Access
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Composite Z-scores of FOXP3-dependent IFNgamma-inducible genes in HT1376 cells
- 25 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Role of Forkhead Box P3 in IFNγ-Mediated PD-L1 Expression and Bladder Cancer Epithelial-to-Mesenchymal Transition
Composite Z-scores of FOXP3-dependent IFNgamma-inducible genes in HT1376 cells